Donate:

Please help support the work of the CIHR Canadian HIV Trials Network (CTN) by contacting the St. Paul’s Foundation by calling 604.806.8912.

Let them know that you would like to direct your donation in support of capacity building activities at the CTN. Your contribution will be used to support activities not funded by our main sponsor that continue to build capacity domestically and internationally and that support CTN’s overall mission of research for treatments, preventions and a cure for HIV/AIDS.

Donations of $25 or more are eligible to receive an official tax receipt.

Our initiatives include:

  • Training new investigators through seminars and international conferences
  • Scaling up clinical trial skills for investigators, clinical research nurses, data managers, and administrators
  • Involving community representation through consultations with those affected and living with HIV and AIDS

For more information on any of our programs or how your support will be used, please contact the CTN at ctninfo@hivnet.ubc.ca or toll-free at 1-800-661-4664.

Thank you for your contribution!

Latest News

The enigma of HIV’s effects on aging

| Uncategorized | No Comments

The average age of people living with HIV in Canada is rising. CTN and BC-CfE researchers are working to understand the factors associated with aging in HIV. This story was originally published by BC-CfE.

Guest Blog: Dr. Haneesha Mohan

| Uncategorized | No Comments

Dr. Haneesha Mohan, CTN Postdoctoral Research Fellow at the University Health Network, describes her work on understanding the metabolic diseases and birth defects potentially caused by ARV medications.

Let’s Talk About Stigma: HIV in 2020

| Uncategorized | No Comments

We talked to three community members to get their unique perspectives on the pervasive impact of HIV-related stigma and what we can do to combat it

Could Cannabis Help Prevent HIV-Related Illnesses?

| Uncategorized | No Comments

CTN Investigators Drs. Cecilia Costiniuk and Ali Jenabian publish a thorough editorial review of cannabis research in HIV and inflammation